secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-002868
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed terminates Executive President Miri Halperin Wernli without cause, effective Feb 28, 2025
--------------------------------------------------------------------------------

- Employment terminated without cause; effective February 28, 2025.
- Reason cited: centralizing management team in the United States for strategic alignment.
- No replacement announced; CEO Robert Barrow remains.
- Updated corporate presentation filed as Exhibit 99.1 on January 13, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925002868/0001104659-25-002868-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925002868/tm253011d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002868

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer